{"chunk_id": "medquad__chunk_34427", "source": "medquad", "text": "y progression of the disease in some infantile-onset cases. Other treatment is symptomatic and supportive. Considerable progress has been made with regard to gene therapy in an animal model of MLD and in clinical trials.,NINDS,Metachromatic Leukodystrophy\nWhat is the outlook for Metachromatic Leukodystrophy ?,The prognosis for MLD is poor. Most children within the infantile form die by age 5. Symptoms of the juvenile form progress with death occurring 10 to 20 years following onset. Those person"}